| |
Generative AI has the potential to accelerate innovations across the value chain, from R&D to commercialization. Watch this webinar series to learn why nine out of the top 10 biopharma organizations use AWS for machine learning and analytics. Watch now. .png)
|
|
Today’s Big NewsAug 28, 2023 |
|
Government Biotechnology Innovation Summit Convenes September 27-28 in National Harbor, MD. Hear from government leaders at the forefront on how biotechnology is transforming the economic, agricultural, healthcare and security landscape of the U.S. Learn more. .png)
|
|
| By Annalee Armstrong This year's Fierce 15 features companies pushing the envelope not only in the lab, in the clinic or on the conference circuit. |
|
|
|
| Philadelphia, PA |  |
|
|
By Kevin Dunleavy Amid supply problems, Novo Nordisk plans to launch its GLP--1 drugs in “more and more” countries, CEO Lars Fruergaard Jørgensen said at a recent Reuters event, though he added that the launches will be "constrained." Meanwhile on Monday, another maker of GLP-1 diabetes drugs, Eli Lilly, will face shortages of Trulicity in Europe through September, according to the European Medicines Agency. |
By Conor Hale For patients with intermittent atrial fibrillation, the company’s Farapulse system was shown to be non-inferior to standard-of-care therapies—including thermal and cryoablation catheters—after one year, offering about the same reduction in arrhythmias. |
By Nick Paul Taylor The long-frozen biotech IPO waters may be thawing slightly—provided you’re one part of a rare breed of biotech. Shortly after RayzeBio filed to go public, Neumora Therapeutics, another well-financed, late-phase business, made its pitch for funding to study treatments for brain diseases including depression. |
|
Wednesday, September 6, 2023 | 2:00 PM ET / 11:00 AM PT Attendees will learn about the latest tools for interacting with medical images, how to guide readers through labeling workflows, and streamlining adjudication and data standardization. Discussions will include real-world use cases of how pharma companies are enhancing AI development by optimizing reader workflows. Register now. 
|
|
By Joseph Keenan Glenmark Pharmaceuticals and Baxter Healthcare issued separate voluntary recalls citing out of specification tests and problems with labels for drugs used to treat hypertension and cancer, respectively. |
By Andrea Park The Inceptiv device has been designed as a closed-loop system, virtually eliminating the need for users to continually tweak their neurostimulation pain therapy based on their movements. |
By James Waldron Things are continuing to look up for Bayer’s Parkinson’s disease cell therapy, with the German pharma giant finally offering a deeper dive into phase 1 data that confirms the candidate hit its key endpoints. |
By Andrea Park Nominations are now open for this year’s list of the fiercest women in pharma, biotech and medtech. |
By Fraiser Kansteiner With many medicines from Pfizer’s Rocky Mount, North Carolina, production plant relegated to an emergency ordering list following a devastating tornado last month, hospitals are likely eager for the massive injectables facility to restart production. Now, Pfizer has clarified the timeline by which it expects manufacturing to resume. |
By Andrea Park TTFields failed to meet its primary endpoint in a trial testing the combination of TTFields and paclitaxel chemotherapy in patients with platinum-resistant tumors, a group that makes up about 20% of all ovarian cancer patients. |
By Max Bayer BridgeBio is expanding on phase 3 data of its cardiovascular med acoramidis months after positive topline results sent the company's stock soaring. BridgeBio still expects to submit an approval application to the FDA before the end of the year. |
Fierce podcasts Don’t miss an episode |
| This week on "The Top Line," we discuss the trends seen at Cannes Lions, the top compensated CEOs in the industry, and the cancer drug shortage |
|
|---|
|
|
Whitepaper Learn how process liquids and buffers impact your total cost of ownership (TCO) and how outsourcing can revolutionize your approach, ensuring quality standards and improving productivity. Sponsored by: Thermo Fisher Scientific Process Liquid Preparation Services |
Whitepaper In oncology, traditional methods for determining sales force size & structure are no longer appropriate. This paper describes the multiple drivers of sales strategy in oncology markets today. Sponsored by: Blue Matter, strategic consultants in the life sciences |
Research Learn how the right chemical inventory strategy helped save a mid-size CDMO millions of dollars while securing a stable supply of products with just-in-time delivery. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
Webinar Download this webinar to learn how to avoid pitfalls when characterizing CAR-T cells in your development workflow, how to save time by using one antibody to examine your entire panel of CARs, and more. Sponsored by: Cell Signaling Technology |
| |
|
